Morning Read: Joslin Diabetes Center CEO forced to resign, Mallinckrodt Pharma subsidiaries want to acquire TGG Medical in $750M deal
Joslin Diabetes Center CEO John Brooks III, has been forced out after four years with the business, two Mallinckrodt Pharmaceuticals subsidiaries are preparing to offer $750 million in unsecured notes to acquire TGG Medical Solutions